INFUSION SITE JOINT MOVEMENT IMPAIRMENT

INFUSION SITE JOINT MOVEMENT IMPAIRMENT was reported 10 times

INFUSION SITE JOINT MOVEMENT IMPAIRMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin Gene-related Peptide Antagonist [EPC] 1 0.0001
1 Alkylating Drug [EPC] 6 0.0000
2 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
3 Platelet Aggregation Inhibitor [EPC] 1 0.0000
4 Proton Pump Inhibitor [EPC] 1 0.0000
5 Benzodiazepine [EPC] 1 0.0000
6 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000